NO20020592L - Fluorenderivater som integrininhibitorer - Google Patents

Fluorenderivater som integrininhibitorer

Info

Publication number
NO20020592L
NO20020592L NO20020592A NO20020592A NO20020592L NO 20020592 L NO20020592 L NO 20020592L NO 20020592 A NO20020592 A NO 20020592A NO 20020592 A NO20020592 A NO 20020592A NO 20020592 L NO20020592 L NO 20020592L
Authority
NO
Norway
Prior art keywords
integrin inhibitors
fluorine derivatives
disorders
nhtv
arteriosclerosis
Prior art date
Application number
NO20020592A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020592D0 (no
Inventor
Wolfgang Staehle
Simon Goodman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20020592D0 publication Critical patent/NO20020592D0/no
Publication of NO20020592L publication Critical patent/NO20020592L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020592A 1999-08-07 2002-02-06 Fluorenderivater som integrininhibitorer NO20020592L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937394A DE19937394A1 (de) 1999-08-07 1999-08-07 Fluorenderivate
PCT/EP2000/007153 WO2001010841A2 (de) 1999-08-07 2000-07-26 Fluorenderivate als integrin inhibitoren

Publications (2)

Publication Number Publication Date
NO20020592D0 NO20020592D0 (no) 2002-02-06
NO20020592L true NO20020592L (no) 2002-04-04

Family

ID=7917613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020592A NO20020592L (no) 1999-08-07 2002-02-06 Fluorenderivater som integrininhibitorer

Country Status (18)

Country Link
EP (1) EP1208088A2 (ja)
JP (1) JP2003506439A (ja)
KR (1) KR20020012631A (ja)
CN (1) CN1368962A (ja)
AR (1) AR025042A1 (ja)
AU (1) AU6828600A (ja)
BR (1) BR0013083A (ja)
CA (1) CA2380981A1 (ja)
CZ (1) CZ2002298A3 (ja)
DE (1) DE19937394A1 (ja)
HK (1) HK1049006A1 (ja)
HU (1) HUP0202464A3 (ja)
MX (1) MXPA02001297A (ja)
NO (1) NO20020592L (ja)
PL (1) PL353054A1 (ja)
SK (1) SK1402002A3 (ja)
WO (1) WO2001010841A2 (ja)
ZA (1) ZA200201873B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102808B1 (ko) * 2010-04-13 2012-01-05 윤태삼 라이저 인장 장치
US8574899B2 (en) 2010-12-22 2013-11-05 Vladimir B Serikov Methods for augmentation collection of placental hematopoietic stem cells and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058925A1 (en) * 1989-06-22 1990-12-23 Moshe Weitzberg Pharmaceutical compositions and methods for treating inflammation
IL113196A0 (en) * 1994-03-31 1995-06-29 Bristol Myers Squibb Co Imidazole derivatives and pharmaceutical compositions containing the same
ES2162676T3 (es) * 1996-03-29 2002-01-01 Searle & Co Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
DE19654483A1 (de) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanin-Derivate
CA2214931A1 (en) * 1996-09-26 1998-03-26 Henry Uhlman Bryant Tetrahydrobenzo-a-fluorene compounds and method of use

Also Published As

Publication number Publication date
HUP0202464A3 (en) 2003-02-28
HK1049006A1 (zh) 2003-04-25
AR025042A1 (es) 2002-11-06
CA2380981A1 (en) 2001-02-15
KR20020012631A (ko) 2002-02-16
BR0013083A (pt) 2002-04-23
WO2001010841A2 (de) 2001-02-15
JP2003506439A (ja) 2003-02-18
MXPA02001297A (es) 2004-07-16
CZ2002298A3 (cs) 2002-04-17
PL353054A1 (en) 2003-10-06
DE19937394A1 (de) 2001-02-08
SK1402002A3 (en) 2002-06-04
HUP0202464A2 (hu) 2002-12-28
NO20020592D0 (no) 2002-02-06
AU6828600A (en) 2001-03-05
WO2001010841A3 (de) 2001-09-07
CN1368962A (zh) 2002-09-11
ZA200201873B (en) 2003-08-27
EP1208088A2 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
NO986090L (no) Fenylalaninderivater som integrininhibitorer
NO20010203L (no) Diacylhydrazinderivater som integrininhibitorer
TW372232B (en) Phenylalanine derivatives
DE60324183D1 (en) Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
DK0539086T3 (da) Kondenserede pyrimidinderivater og deres anvendelse som angiotensin II-antagonister
CY1107475T1 (el) Αναστολεις ρο-κινασης
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
MY142915A (en) Rho-kinase inhibitors
NO20021781L (no) Heteroalkylamino-substituerte bicykliske nitrogenheterocykler som inhibitorer for P38-proteinkinase
HK1063781A1 (en) Pyrazole derivatives for treating hiv
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
CA2280727A1 (en) Bicyclic amino acids
DK1259485T3 (da) Benzamider og beslægtede inhibitorer for faktor Xa
NO20076502L (no) Pyrrolopyridiner nyttige som inhibitorer av proteinkinase
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
CA2348391A1 (en) Chromenone and chromanone derivatives as integrin inhibitors
NO20051967L (no) 3,4-disubstituerte pyroler og deres anvendelse ved behandling av inflammatoriske sykdommer.
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
NO308897B1 (no) Benzotiazin-dioksyder som endotelin-antagonister, fremgangsmÕter for fremstilling derav, farmasøytiske preparater omfattende forbindelsene, samt anvendelse av forbindelsene
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
WO2003059258A3 (en) Compositions and methods for treating heart failure
WO2003059265A3 (en) Compositions and methods for treating heart failure
HUP0105479A2 (hu) Béta-alanin-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
NO20020031L (no) Dihydrobenzodiazepiner og deres anvendelse til behandling av dyslipidemi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application